Halliburton Company officer updates insider holdings in amended report. The President - Eastern Hemisphere of Halliburton, filing individually, corrected his direct beneficial ownership after an administrative error was identified.
Following the correction, he directly holds 147,163.837 shares of Halliburton common stock. He also holds several stock options: an option to buy 11,775 shares at $24.68 per share exercisable until 01/02/2030, an option to buy 9,517 shares at $27.30 per share until 01/02/2029, an option to buy 4,323 shares at $49.61 per share until 01/02/2028, and an option to buy 7,829 shares at $43.84 per share until 08/14/2026. The issuer is Halliburton Co (HAL), and the earliest transaction date reported is 01/02/2026.
Halliburton Company updated the reported holdings of its President - Eastern Hemisphere, Mr. Yassine, due to an earlier administrative error. The corrected filing shows he directly beneficially owns 106,007.837 shares of common stock as of January 1, 2026.
He also holds several stock options to buy Halliburton common stock, including 11,775 shares at $24.68 expiring January 2, 2030, 9,517 shares at $27.30 expiring January 2, 2029, 4,323 shares at $49.61 expiring January 2, 2028, and 7,829 shares at $43.84 expiring August 14, 2026. The change reflects a correction to his initial statement filed January 2, 2026, which had understated his direct beneficial ownership.
Halliburton Company executive reports stock award and planned share sale
A Halliburton Company executive serving as EVP and Chief Administrative Officer reported equity transactions in Halliburton common stock. On January 2, 2026, the reporting person acquired 34,968 shares of common stock pursuant to the Halliburton Company Stock and Incentive Plan, which allows surrender of shares to satisfy tax withholding. The closing price of Halliburton common stock on the New York Stock Exchange on that grant date was $29.60 per share.
On January 5, 2026, the executive sold 100,000 shares of common stock at a price of $32.25 per share pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2025. Following these transactions, the executive directly beneficially owned 419,799.685 shares of Halliburton common stock and held vested stock options covering additional shares with exercise prices between $31.44 and $53.54.
Halliburton Company reported an insider equity award for a senior executive. On January 2, 2026, a director and Executive Vice President & Chief Operating Officer received 56,178 shares of common stock under the Halliburton Company Stock and Incentive Plan. The plan allows shares to be surrendered to Halliburton to cover tax withholding obligations. The closing price of Halliburton common stock on the New York Stock Exchange on the grant date was $29.60 per share. After this grant, the insider directly beneficially owned 219,229.952 shares of common stock. The filing also shows stock options with exercise prices of $55.68 (3,722 shares, expiring January 3, 2027) and $49.61 (12,090 shares, expiring January 2, 2028), while an older option expiring January 4, 2026 is now at zero.
Halliburton Company executive equity update: A Halliburton Co (HAL) officer, listed as President - Western Hemisphere, reported receiving 41,156 shares of common stock on 01/02/2026 under the Halliburton Company Stock and Incentive Plan. The grant is valued using the New York Stock Exchange closing price of $29.60 on the grant date. After this award, the reporting person beneficially owns 488,160.517 Halliburton shares, which includes 2,013.910 shares accumulated through dividend reinvestment as of December 31, 2025. The filing also notes a stock option for 28,604 shares at an exercise price of $34.48 that expired on January 4, 2026, while other options remain outstanding with exercise prices between $27.14 and $55.68 and expirations in 2027 and 2028.
Halliburton Company reported that its Senior Vice President and Treasurer acquired additional common stock through an equity award. On January 2, 2026, the officer was granted 5,610 shares of common stock under the Halliburton Company Stock and Incentive Plan, which allows shares to be surrendered to cover withholding taxes. The grant used the New York Stock Exchange closing price of $29.60 per share on the grant date. Following this award, the officer directly owned 82,736 shares of Halliburton common stock. The filing also lists existing stock options to buy Halliburton common shares at exercise prices of $31.44, $43.38, and $53.54, with expiration dates ranging from December 2026 to December 2028.
Halliburton Company executive reports new stock award. A senior vice president of Halliburton received an award of 5,610 shares of common stock on January 2, 2026 under the Halliburton Company Stock and Incentive Plan. The plan allows shares to be surrendered back to Halliburton to cover tax withholding.
After this grant, the executive beneficially owns 51,738.081 shares of Halliburton common stock directly, which includes 937.667 shares acquired through the Employee Stock Purchase Plan for periods ending March 31, 2025 and June 30, 2025. The executive also holds vested options to buy 16,733 shares at $49.61 expiring January 2, 2028 and 14,197 shares at $55.68 expiring January 3, 2027.
Halliburton Company executive Sarah I. Rubenfeld, SVP & Chief Accounting Officer, reported a new stock award in company shares. On 01/02/2026 she acquired 5,610 shares of Halliburton common stock under the Halliburton Company Stock and Incentive Plan, based on a New York Stock Exchange closing price of $29.60 on the grant date. The plan allows shares to be surrendered back to Halliburton to cover tax withholding obligations.
After this grant, she beneficially owns 73,310.422 Halliburton shares, which includes 15.422 shares purchased through the Employee Stock Purchase Plan for the period ending September 30, 2025. She also holds options to buy 9,688 shares at an exercise price of $49.61 exercisable from January 2, 2018 until January 2, 2028, and options to buy 7,994 shares at $55.68 exercisable from January 3, 2017 until January 3, 2027.
Halliburton Company executive insider activity: The President - Eastern Hemisphere of Halliburton reported equity transactions effective 01/02/2026. The executive received 41,156 shares of common stock under the Halliburton Company Stock and Incentive Plan, with the grant referenced to a closing share price of $29.60. The filing also shows the vesting of 3,552 restricted stock units from an award granted in January 2025, which converted into common shares.
After these transactions, the executive beneficially owned 70,991 shares of Halliburton common stock directly. The report lists remaining derivative holdings, including 14,204 restricted stock units and several stock option awards with exercise prices ranging from $24.68 to $49.61 and expirations between 2026 and 2030. Each restricted stock unit represents the right to receive one share of common stock as it vests in equal annual installments.
Halliburton Company disclosed an insider equity transaction by its Executive Vice President & Chief Financial Officer. On January 2, 2026, the officer acquired 37,548 shares of common stock as an award under the Halliburton Company Stock and Incentive Plan at the New York Stock Exchange closing price of $29.60 per share on the grant date. Following this award, the officer beneficially owned 159,719.623 shares, which includes 166.852 shares accumulated through dividend reinvestment as of December 31, 2025. The filing also notes that a stock option covering 9,534 shares with a $34.48 exercise price expired on January 4, 2026, while other stock options remain outstanding.